EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $39,949 | -31.5% | 2,055 | 0.0% | 0.00% | – |
| Q1 2023 | $58,300 | -21.0% | 2,055 | -18.6% | 0.00% | – |
| Q4 2022 | $73,777 | +6.9% | 2,524 | -3.8% | 0.00% | – |
| Q3 2022 | $69,000 | -41.0% | 2,623 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $117,000 | -11.4% | 2,623 | -1.6% | 0.00% | 0.0% |
| Q1 2022 | $132,000 | +25.7% | 2,665 | +29.7% | 0.00% | 0.0% |
| Q4 2021 | $105,000 | -8.7% | 2,055 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $115,000 | +30.7% | 2,055 | 0.0% | 0.00% | – |
| Q2 2021 | $88,000 | +2.3% | 2,055 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $86,000 | -10.4% | 2,055 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $96,000 | +10.3% | 2,055 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $87,000 | -12.1% | 2,055 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $99,000 | +125.0% | 2,055 | +114.1% | 0.00% | – |
| Q1 2020 | $44,000 | -24.1% | 960 | 0.0% | 0.00% | – |
| Q4 2019 | $58,000 | +7.4% | 960 | 0.0% | 0.00% | – |
| Q3 2019 | $54,000 | +1.9% | 960 | 0.0% | 0.00% | – |
| Q2 2019 | $53,000 | +10.4% | 960 | 0.0% | 0.00% | – |
| Q1 2019 | $48,000 | +23.1% | 960 | 0.0% | 0.00% | – |
| Q4 2018 | $39,000 | -41.8% | 960 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $67,000 | -8.2% | 960 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $73,000 | +204.2% | 960 | +112.9% | 0.00% | – |
| Q1 2018 | $24,000 | 0.0% | 451 | 0.0% | 0.00% | – |
| Q4 2017 | $24,000 | -11.1% | 451 | 0.0% | 0.00% | – |
| Q3 2017 | $27,000 | -25.0% | 451 | 0.0% | 0.00% | – |
| Q2 2017 | $36,000 | -2.7% | 451 | 0.0% | 0.00% | – |
| Q1 2017 | $37,000 | +2.8% | 451 | 0.0% | 0.00% | – |
| Q4 2016 | $36,000 | +33.3% | 451 | +16.8% | 0.00% | – |
| Q3 2016 | $27,000 | +80.0% | 386 | 0.0% | 0.00% | – |
| Q2 2016 | $15,000 | -6.2% | 386 | 0.0% | 0.00% | – |
| Q1 2016 | $16,000 | -52.9% | 386 | 0.0% | 0.00% | – |
| Q4 2015 | $34,000 | +385.7% | 386 | +315.1% | 0.00% | – |
| Q3 2015 | $7,000 | – | 93 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |